| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 1.83e-06 | 40 | 187 | 6 | GO:0140662 | |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 MATN3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 DNAH7 TENM2 ITPR2 VCAN RHBDL3 PCDH15 DSG4 PCDHB1 PCDH8 HSPA5 | 7.68e-06 | 749 | 187 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | protein folding chaperone | 6.30e-05 | 73 | 187 | 6 | GO:0044183 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSPA4L VPS4A KIF1B CHD1 CLPX DNAH7 ATP8B2 DNAH1 MFSD2A RUVBL1 NAV2 KIF5B ATP2A3 HSPA2 HSPA4 HSPA5 HSPA9 | 6.89e-05 | 614 | 187 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC35A1 SLC19A2 SLC39A4 MFSD12 SFXN1 SLC7A2 MFSD2A SFXN5 SLC26A7 SFXN3 SLC17A6 | 1.04e-04 | 293 | 187 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC19A2 MFSD12 SFXN1 SLC7A2 MFSD2A SFXN5 SLC26A7 SFXN3 SLC17A6 | 1.50e-04 | 207 | 187 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC19A2 MFSD12 SFXN1 SLC7A2 MFSD2A SFXN5 SLC26A7 SFXN3 SLC17A6 | 1.56e-04 | 208 | 187 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | VPS4A KIF1B CHD1 CLPX DNAH7 ATP8B2 RUVBL1 NAV2 KIF5B ATP2A3 HSPA2 HSPA5 HSPA9 | 2.76e-04 | 441 | 187 | 13 | GO:0016887 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PRTG PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PKD1 PCDH15 ROBO2 DSG4 ROBO3 PCDHB1 PCDH8 SDK1 | 6.94e-15 | 187 | 186 | 19 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PRTG PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 TENM2 PKD1 PCDH15 ROBO2 DSG4 CLDN19 ROBO3 PCDHB1 PCDH8 SDK1 UNC5D | 1.02e-13 | 313 | 186 | 22 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PRTG PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 TENM2 LEP NRXN2 PKD1 PCDH15 ROBO2 COL14A1 DLG4 NLGN2 DSG4 CLDN19 ROBO3 PCDHB1 PCDH8 SDK1 UNC5D IL7R | 4.30e-07 | 1077 | 186 | 28 | GO:0098609 |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 1.07e-05 | 16 | 186 | 4 | GO:0051290 | |
| Domain | Cadherin_CS | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDH15 DSG4 PCDHB1 PCDH8 | 4.05e-12 | 109 | 186 | 14 | IPR020894 |
| Domain | CADHERIN_1 | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDH15 DSG4 PCDHB1 PCDH8 | 6.69e-12 | 113 | 186 | 14 | PS00232 |
| Domain | Cadherin | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDH15 DSG4 PCDHB1 PCDH8 | 6.69e-12 | 113 | 186 | 14 | PF00028 |
| Domain | CADHERIN_2 | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDH15 DSG4 PCDHB1 PCDH8 | 7.57e-12 | 114 | 186 | 14 | PS50268 |
| Domain | - | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDH15 DSG4 PCDHB1 PCDH8 | 7.57e-12 | 114 | 186 | 14 | 2.60.40.60 |
| Domain | CA | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDH15 DSG4 PCDHB1 PCDH8 | 8.54e-12 | 115 | 186 | 14 | SM00112 |
| Domain | Cadherin-like | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDH15 DSG4 PCDHB1 PCDH8 | 9.63e-12 | 116 | 186 | 14 | IPR015919 |
| Domain | Cadherin | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 FAT3 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDH15 DSG4 PCDHB1 PCDH8 | 1.22e-11 | 118 | 186 | 14 | IPR002126 |
| Domain | Cadherin_2 | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 PCDH8 | 3.98e-11 | 65 | 186 | 11 | PF08266 |
| Domain | Cadherin_N | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 PCDH8 | 3.98e-11 | 65 | 186 | 11 | IPR013164 |
| Domain | Cadherin_C | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHB1 | 7.35e-09 | 42 | 186 | 8 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHB1 | 7.35e-09 | 42 | 186 | 8 | PF16492 |
| Domain | Cadherin_tail | 6.94e-08 | 37 | 186 | 7 | PF15974 | |
| Domain | Cadherin_CBD | 6.94e-08 | 37 | 186 | 7 | IPR031904 | |
| Domain | - | 6.95e-08 | 12 | 186 | 5 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 6.95e-08 | 12 | 186 | 5 | IPR029047 | |
| Domain | - | 1.12e-07 | 13 | 186 | 5 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.12e-07 | 13 | 186 | 5 | IPR018181 | |
| Domain | HSP70_C | 1.12e-07 | 13 | 186 | 5 | IPR029048 | |
| Domain | HSP70 | 3.71e-07 | 16 | 186 | 5 | PF00012 | |
| Domain | HSP70_2 | 5.21e-07 | 17 | 186 | 5 | PS00329 | |
| Domain | HSP70_1 | 5.21e-07 | 17 | 186 | 5 | PS00297 | |
| Domain | HSP70_3 | 5.21e-07 | 17 | 186 | 5 | PS01036 | |
| Domain | fn3 | FNDC3B COL7A1 PRTG SPEG IGSF22 PTPRJ ROBO2 COL14A1 ROBO3 SDK1 IL7R | 6.89e-07 | 162 | 186 | 11 | PF00041 |
| Domain | Hsp_70_fam | 7.16e-07 | 18 | 186 | 5 | IPR013126 | |
| Domain | FN3 | FNDC3B COL7A1 PRTG SPEG IGSF22 PTPRJ ROBO2 COL14A1 ROBO3 SDK1 IL7R | 5.14e-06 | 199 | 186 | 11 | PS50853 |
| Domain | FN3_dom | FNDC3B COL7A1 PRTG SPEG IGSF22 PTPRJ ROBO2 COL14A1 ROBO3 SDK1 IL7R | 8.20e-06 | 209 | 186 | 11 | IPR003961 |
| Domain | Mtc | 9.58e-06 | 5 | 186 | 3 | PF03820 | |
| Domain | Mtc | 9.58e-06 | 5 | 186 | 3 | IPR004686 | |
| Domain | FN3 | FNDC3B COL7A1 PRTG SPEG IGSF22 PTPRJ ROBO2 COL14A1 ROBO3 SDK1 | 1.69e-05 | 185 | 186 | 10 | SM00060 |
| Domain | DUF4203 | 9.86e-05 | 2 | 186 | 2 | IPR025256 | |
| Domain | DUF4203 | 9.86e-05 | 2 | 186 | 2 | PF13886 | |
| Domain | Ig_I-set | 1.24e-04 | 190 | 186 | 9 | IPR013098 | |
| Domain | I-set | 1.24e-04 | 190 | 186 | 9 | PF07679 | |
| Domain | IGc2 | PRTG UNC5B SPEG IGSF22 WFIKKN1 VSIG10L ROBO2 ROBO3 SDK1 UNC5D | 1.27e-04 | 235 | 186 | 10 | SM00408 |
| Domain | Ig_sub2 | PRTG UNC5B SPEG IGSF22 WFIKKN1 VSIG10L ROBO2 ROBO3 SDK1 UNC5D | 1.27e-04 | 235 | 186 | 10 | IPR003598 |
| Domain | Ig-like_fold | FNDC3B COL7A1 PRTG UNC5B SPEG IGSF22 PTPRJ WFIKKN1 VCAN SEMA3B VSIG10L ROBO2 COL14A1 SEMA4A ROBO3 SDK1 UNC5D IL7R | 2.52e-04 | 706 | 186 | 18 | IPR013783 |
| Domain | RNA_pol_Rpb1_2 | 2.94e-04 | 3 | 186 | 2 | PF00623 | |
| Domain | RNA_pol_asu | 2.94e-04 | 3 | 186 | 2 | IPR000722 | |
| Domain | RNA_pol_N | 2.94e-04 | 3 | 186 | 2 | IPR006592 | |
| Domain | RNA_pol_Rpb1_1 | 2.94e-04 | 3 | 186 | 2 | PF04997 | |
| Domain | RNA_pol_Rpb1_5 | 2.94e-04 | 3 | 186 | 2 | PF04998 | |
| Domain | RNA_pol_Rpb1_3 | 2.94e-04 | 3 | 186 | 2 | PF04983 | |
| Domain | RNA_pol_Rpb1_4 | 2.94e-04 | 3 | 186 | 2 | PF05000 | |
| Domain | RPOLA_N | 2.94e-04 | 3 | 186 | 2 | SM00663 | |
| Domain | RNA_pol_Rpb1_4 | 2.94e-04 | 3 | 186 | 2 | IPR007083 | |
| Domain | RNA_pol_Rpb1_5 | 2.94e-04 | 3 | 186 | 2 | IPR007081 | |
| Domain | RNA_pol_Rpb1_1 | 2.94e-04 | 3 | 186 | 2 | IPR007080 | |
| Domain | RNA_pol_Rpb1_3 | 2.94e-04 | 3 | 186 | 2 | IPR007066 | |
| Domain | CARBOXYLESTERASE_B_2 | 3.26e-04 | 14 | 186 | 3 | PS00941 | |
| Domain | COesterase | 3.26e-04 | 14 | 186 | 3 | PF00135 | |
| Domain | CarbesteraseB | 3.26e-04 | 14 | 186 | 3 | IPR002018 | |
| Domain | Gal_Oxidase_b-propeller | 3.50e-04 | 34 | 186 | 4 | IPR015916 | |
| Domain | - | FNDC3B COL7A1 PRTG UNC5B SPEG IGSF22 PTPRJ WFIKKN1 VCAN SEMA3B VSIG10L ROBO2 COL14A1 ROBO3 SDK1 UNC5D IL7R | 3.52e-04 | 663 | 186 | 17 | 2.60.40.10 |
| Domain | BTB-kelch_protein | 8.68e-04 | 43 | 186 | 4 | IPR017096 | |
| Domain | UPA | 9.67e-04 | 5 | 186 | 2 | PF17217 | |
| Domain | UPA | 9.67e-04 | 5 | 186 | 2 | IPR033772 | |
| Domain | IG | PRTG UNC5B SPEG IGSF22 WFIKKN1 VCAN SEMA3B VSIG10L ROBO2 ROBO3 SDK1 UNC5D | 1.08e-03 | 421 | 186 | 12 | SM00409 |
| Domain | Ig_sub | PRTG UNC5B SPEG IGSF22 WFIKKN1 VCAN SEMA3B VSIG10L ROBO2 ROBO3 SDK1 UNC5D | 1.08e-03 | 421 | 186 | 12 | IPR003599 |
| Domain | Quino_amine_DH_bsu | 1.30e-03 | 22 | 186 | 3 | IPR011044 | |
| Domain | OSR1_C | 1.44e-03 | 6 | 186 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.44e-03 | 6 | 186 | 2 | IPR024678 | |
| Domain | ADH_SHORT | 1.91e-03 | 53 | 186 | 4 | PS00061 | |
| Domain | adh_short | 2.19e-03 | 55 | 186 | 4 | PF00106 | |
| Domain | SDR_fam | 2.34e-03 | 56 | 186 | 4 | IPR002347 | |
| Domain | - | 2.38e-03 | 27 | 186 | 3 | 2.130.10.80 | |
| Domain | Carboxylesterase_B_AS | 2.66e-03 | 8 | 186 | 2 | IPR019826 | |
| Domain | CARBOXYLESTERASE_B_1 | 2.66e-03 | 8 | 186 | 2 | PS00122 | |
| Domain | Kelch | 2.66e-03 | 58 | 186 | 4 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 2.83e-03 | 59 | 186 | 4 | IPR011043 | |
| Domain | BACK | 3.01e-03 | 60 | 186 | 4 | SM00875 | |
| Domain | BACK | 3.19e-03 | 61 | 186 | 4 | IPR011705 | |
| Domain | BACK | 3.19e-03 | 61 | 186 | 4 | PF07707 | |
| Domain | ZU5 | 3.39e-03 | 9 | 186 | 2 | SM00218 | |
| Domain | TSP_1 | 3.59e-03 | 63 | 186 | 4 | PF00090 | |
| Domain | IG_LIKE | PRTG UNC5B SPEG IGSF22 WFIKKN1 VCAN SEMA3B VSIG10L ROBO2 ROBO3 SDK1 UNC5D | 3.84e-03 | 491 | 186 | 12 | PS50835 |
| Domain | TSP1 | 4.02e-03 | 65 | 186 | 4 | SM00209 | |
| Domain | TSP1_rpt | 4.02e-03 | 65 | 186 | 4 | IPR000884 | |
| Domain | TSP1 | 4.02e-03 | 65 | 186 | 4 | PS50092 | |
| Domain | A2M | 4.21e-03 | 10 | 186 | 2 | PF00207 | |
| Domain | A2M_N_2 | 4.21e-03 | 10 | 186 | 2 | IPR011625 | |
| Domain | A2M_comp | 4.21e-03 | 10 | 186 | 2 | IPR011626 | |
| Domain | A2M_recep | 4.21e-03 | 10 | 186 | 2 | PF07677 | |
| Domain | A2M_comp | 4.21e-03 | 10 | 186 | 2 | PF07678 | |
| Domain | A2M_N | 4.21e-03 | 10 | 186 | 2 | PF01835 | |
| Domain | A2M_N | 4.21e-03 | 10 | 186 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 4.21e-03 | 10 | 186 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 4.21e-03 | 10 | 186 | 2 | PS00477 | |
| Domain | ZU5 | 4.21e-03 | 10 | 186 | 2 | PS51145 | |
| Domain | A2M_N_2 | 4.21e-03 | 10 | 186 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 4.21e-03 | 10 | 186 | 2 | IPR001599 | |
| Domain | Ig-like_dom | PRTG UNC5B SPEG IGSF22 WFIKKN1 VCAN SEMA3B VSIG10L ROBO2 ROBO3 SDK1 UNC5D | 4.65e-03 | 503 | 186 | 12 | IPR007110 |
| Domain | Sc_DH/Rdtase_CS | 5.03e-03 | 35 | 186 | 3 | IPR020904 | |
| Domain | RhoGEF | 5.24e-03 | 70 | 186 | 4 | PF00621 | |
| Domain | DH_2 | 5.24e-03 | 70 | 186 | 4 | PS50010 | |
| Domain | Kelch_1 | 5.24e-03 | 70 | 186 | 4 | PF01344 | |
| Domain | Kelch_1 | 5.24e-03 | 70 | 186 | 4 | IPR006652 | |
| Domain | - | 5.51e-03 | 71 | 186 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 5.51e-03 | 71 | 186 | 4 | IPR000219 | |
| Domain | SSF | 6.10e-03 | 12 | 186 | 2 | PF00474 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 PCDH8 | 1.13e-13 | 68 | 190 | 11 | 11230163 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 PCDH8 | 2.18e-13 | 72 | 190 | 11 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 PCDH8 | 2.99e-13 | 74 | 190 | 11 | 10817752 |
| Pubmed | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 PCDH8 | 4.72e-13 | 77 | 190 | 11 | 10835267 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 | 6.45e-13 | 57 | 190 | 10 | 32633719 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 PCDH8 | 7.29e-13 | 80 | 190 | 11 | 10716726 |
| Pubmed | 1.02e-10 | 44 | 190 | 8 | 19029045 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 1.40e-10 | 28 | 190 | 7 | 15347688 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 | 1.04e-09 | 58 | 190 | 8 | 30377227 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | H2AZ2 HSDL2 CISD1 HSPA4L VPS4A POLE POLR2A DUSP9 PSMB5 RDH13 PFKL CLPX RRM1 POLR3A SFXN1 RUVBL1 KLHL21 FBXO7 CPSF1 H2AZ1 GMDS KIF5B HSPA2 HSPA4 HSPA5 VARS1 HSPA9 | 1.39e-09 | 1257 | 190 | 27 | 37317656 |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | VPS4A RUVBL1 XPNPEP3 SFXN3 PKD1 PCDH15 KIF5B ATP2A3 HSPA2 HSPA5 HSPA9 | 1.18e-08 | 195 | 190 | 11 | 17110338 |
| Pubmed | 1.33e-08 | 15 | 190 | 5 | 23515096 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRAF2 HSDL2 HSPA4L CPSF6 VPS4A POLE POLR2A PSMB5 CHD1 PFKL CLPX NDUFV1 POLR3A SFXN1 MRM3 RUVBL1 SFXN3 CPSF1 H2AZ1 FGD5 KIF5B ATM HSPA4 HSPA5 VARS1 HSPA9 | 7.69e-08 | 1425 | 190 | 26 | 30948266 |
| Pubmed | 1.06e-07 | 9 | 190 | 4 | 21763498 | ||
| Pubmed | 1.06e-07 | 9 | 190 | 4 | 8486356 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | EPPK1 HSPA4L VPS4A PSMB5 TMOD2 PFKL SFXN1 PJA2 RUVBL1 AARS2 XPNPEP3 SFXN3 PZP ATP2A3 HSPA4 HSPA5 HSPA9 | 1.17e-07 | 647 | 190 | 17 | 26618866 |
| Pubmed | 1.22e-07 | 146 | 190 | 9 | 29509794 | ||
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 1.77e-07 | 10 | 190 | 4 | 11932435 | |
| Pubmed | 1.77e-07 | 10 | 190 | 4 | 12832005 | ||
| Pubmed | 1.77e-07 | 10 | 190 | 4 | 19171884 | ||
| Pubmed | 1.77e-07 | 10 | 190 | 4 | 7906708 | ||
| Pubmed | 2.24e-07 | 25 | 190 | 5 | 27483141 | ||
| Pubmed | 3.20e-07 | 50 | 190 | 6 | 23703321 | ||
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 3.63e-07 | 166 | 190 | 9 | 35687106 | |
| Pubmed | HIV-1 viral protein R (Vpr) and its interactions with host cell. | 4.13e-07 | 12 | 190 | 4 | 19275587 | |
| Pubmed | 6.39e-07 | 4 | 190 | 3 | 19659607 | ||
| Pubmed | H2AZ2 CPSF6 IFT172 PFKL EMSY RUVBL1 LIPG KLHL21 CPSF1 H2AZ1 DSG4 ATP2A3 HSPA2 HSPA9 | 1.02e-06 | 513 | 190 | 14 | 25798074 | |
| Pubmed | 1.12e-06 | 15 | 190 | 4 | 10964507 | ||
| Pubmed | Functional significance of isoform diversification in the protocadherin gamma gene cluster. | 1.13e-06 | 34 | 190 | 5 | 22884324 | |
| Pubmed | 1.27e-06 | 99 | 190 | 7 | 27746211 | ||
| Pubmed | Clathrin facilitates the morphogenesis of retrovirus particles. | 1.49e-06 | 16 | 190 | 4 | 21738476 | |
| Pubmed | Regulation of axon guidance by compartmentalized nonsense-mediated mRNA decay. | 1.59e-06 | 5 | 190 | 3 | 23746841 | |
| Pubmed | SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism. | 1.59e-06 | 5 | 190 | 3 | 30442778 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | KIF1B KCNAB2 TMOD2 CHD1 PFKL NDUFV1 SFXN1 SFXN5 SFXN3 DLG4 KIF5B ATP2A3 HSPA2 HSPA5 HSPA9 | 1.88e-06 | 621 | 190 | 15 | 22794259 |
| Pubmed | 1.94e-06 | 17 | 190 | 4 | 18279309 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PCDHGB1 B3GALNT2 KIF1B TM7SF3 PFKL TEP1 PLBD2 SH2B1 LRCH3 DNAH1 SFXN1 PTPRJ MICAL2 PLEKHG3 LMLN XPNPEP3 SEMA3B SFXN3 PAK3 FOLH1B NLGN2 OXSR1 CSMD1 ZSWIM4 | 2.26e-06 | 1489 | 190 | 24 | 28611215 |
| Pubmed | 3.17e-06 | 6 | 190 | 3 | 17184779 | ||
| Pubmed | EPPK1 KCNAB2 RDH13 PFKL NDUFV1 ITPR2 VCAN XPNPEP3 DLG4 DECR2 STK39 NLGN2 | 4.91e-06 | 430 | 190 | 12 | 32581705 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FNDC3B TRAF2 VPS4A POLE POLR2A PSMB5 CHD1 PFKL CLPX RRM1 POLR3A SFXN1 RUVBL1 MICAL2 PLEKHG3 SFXN3 CPSF1 KIF5B HSPA4 HSPA5 VARS1 HSPA9 | 5.39e-06 | 1353 | 190 | 22 | 29467282 |
| Pubmed | HSDL2 CISD1 DUSP9 DOLK RRM1 ALKBH5 PLBD2 NDUFV1 CKMT2 AARS2 CPSF1 STK39 OXSR1 HSPA9 HSD17B8 | 6.26e-06 | 686 | 190 | 15 | 28380382 | |
| Pubmed | 8.42e-06 | 24 | 190 | 4 | 10617616 | ||
| Pubmed | 8.42e-06 | 24 | 190 | 4 | 24698270 | ||
| Pubmed | 8.81e-06 | 8 | 190 | 3 | 11274051 | ||
| Pubmed | 8.81e-06 | 8 | 190 | 3 | 30591555 | ||
| Pubmed | 9.74e-06 | 52 | 190 | 5 | 26633812 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL7A1 MAN2A2 HSPA4L B3GALNT2 SLC35A1 SREBF1 RRM1 PLBD2 ITPR2 RUVBL1 PTPRJ MICAL2 BTD SEMA3B CPSF1 KIF5B ATM ATP2A3 HSPA2 HSPA5 | 1.05e-05 | 1201 | 190 | 20 | 35696571 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPPK1 H2AZ2 HSDL2 HSPA4L CPSF6 POLR2A PSMB5 CHD1 RDH13 PFKL CLPX RRM1 MRM3 RUVBL1 XPNPEP3 GMDS DECR2 KIF5B HSPA4 HSPA5 VARS1 HSPA9 | 1.09e-05 | 1415 | 190 | 22 | 28515276 |
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 1.33e-05 | 141 | 190 | 7 | 32322062 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 H2AZ2 CPSF6 POLR2A CHD1 PFKL ITPR2 SFXN1 RUVBL1 AARS2 PLEKHG3 XPNPEP3 CPSF1 KIF5B HSPA4 HSPA5 VARS1 HSPA9 | 1.46e-05 | 1024 | 190 | 18 | 24711643 |
| Pubmed | CTU2 CPSF6 VPS4A POLR2A CLPX RRM1 SFXN1 MRM3 CPSF1 STK39 OXSR1 KIF5B HSPA5 HSPA9 | 1.60e-05 | 653 | 190 | 14 | 33742100 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPPK1 CPSF6 KIF1B PSMB5 PFKL CLPX RRM1 PLBD2 EMSY SFXN1 RUVBL1 AARS2 SFXN3 H2AZ1 STK39 OXSR1 KIF5B HSPA4 HSPA5 VARS1 HSPA9 | 2.08e-05 | 1367 | 190 | 21 | 32687490 |
| Pubmed | 2.12e-05 | 30 | 190 | 4 | 25864199 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | HSPA4L CPSF6 AMDHD2 KCNAB2 PFKL CLPX KIF5B HSPA4 VARS1 HSPA9 | 2.17e-05 | 344 | 190 | 10 | 30333137 |
| Pubmed | Activator-Mediator binding regulates Mediator-cofactor interactions. | 2.56e-05 | 11 | 190 | 3 | 20534441 | |
| Pubmed | 2.56e-05 | 11 | 190 | 3 | 9647694 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | TRAF2 EPPK1 HSPA4L CPSF6 POLE POLR2A PCDHB5 KIF1B PSMB5 ALS2 CHD1 CLPX SFXN1 MRM3 RUVBL1 RHPN2 OXSR1 KIF5B ATP2A3 VARS1 | 2.72e-05 | 1284 | 190 | 20 | 17353931 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.96e-05 | 219 | 190 | 8 | 31353912 | |
| Pubmed | Regulation of OSR1 and the sodium, potassium, two chloride cotransporter by convergent signals. | 2.97e-05 | 2 | 190 | 2 | 24191005 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 28383761 | ||
| Pubmed | PHRF1 promotes migration and invasion by modulating ZEB1 expression. | 2.97e-05 | 2 | 190 | 2 | 32730336 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 24173353 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 19264154 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 23034389 | ||
| Pubmed | FBXO7 Y52C polymorphism as a potential protective factor in Parkinson's disease. | 2.97e-05 | 2 | 190 | 2 | 25029497 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 22613557 | ||
| Pubmed | SPAK and OSR1 Sensitive Cell Membrane Protein Abundance and Activity of KCNQ1/E1 K+ Channels. | 2.97e-05 | 2 | 190 | 2 | 26584301 | |
| Pubmed | SH2B1 in β-cells promotes insulin expression and glucose metabolism in mice. | 2.97e-05 | 2 | 190 | 2 | 24645678 | |
| Pubmed | H2A.Z is dispensable for both basal and activated transcription in post-mitotic mouse muscles. | 2.97e-05 | 2 | 190 | 2 | 32266374 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 32868857 | ||
| Pubmed | Role of the WNK-activated SPAK kinase in regulating blood pressure. | 2.97e-05 | 2 | 190 | 2 | 20091762 | |
| Pubmed | Role of polycystin-1 in bone remodeling: orthodontic tooth movement study in mutant mice. | 2.97e-05 | 2 | 190 | 2 | 24559508 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 24449167 | ||
| Pubmed | The replacement histone H2A.Z in a hyperacetylated form is a feature of active genes in the chicken. | 2.97e-05 | 2 | 190 | 2 | 16204459 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 16953841 | ||
| Pubmed | Characterization of the histone H2A.Z-1 and H2A.Z-2 isoforms in vertebrates. | 2.97e-05 | 2 | 190 | 2 | 20003410 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 10514488 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 19017364 | ||
| Pubmed | Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity. | 2.97e-05 | 2 | 190 | 2 | 19739077 | |
| Pubmed | Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia. | 2.97e-05 | 2 | 190 | 2 | 8789452 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 10524232 | ||
| Pubmed | Identification and characterization of a novel mitochondrial tricarboxylate carrier. | 2.97e-05 | 2 | 190 | 2 | 12150972 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 21836059 | ||
| Pubmed | Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter. | 2.97e-05 | 2 | 190 | 2 | 16382158 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 28912580 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 27444648 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 9199932 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 29668871 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 33226729 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 33802342 | ||
| Pubmed | H2A.Z facilitates licensing and activation of early replication origins. | 2.97e-05 | 2 | 190 | 2 | 31875854 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 22528773 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 24719326 | ||
| Pubmed | Histone H2A.Z is required for androgen receptor-mediated effects on fear memory. | 2.97e-05 | 2 | 190 | 2 | 32916283 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 16329989 | ||
| Pubmed | The Ste20 kinases SPAK and OSR1 travel between cells through exosomes. | 2.97e-05 | 2 | 190 | 2 | 27122160 | |
| Pubmed | PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy. | 2.97e-05 | 2 | 190 | 2 | 39137120 | |
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 36293397 | ||
| Pubmed | 2.97e-05 | 2 | 190 | 2 | 26673921 | ||
| Pubmed | ALKBH5 Suppresses Autophagy in Prostate Cancer Cells via Inhibiting m6A-Modification of TSPAN1 mRNA. | 2.97e-05 | 2 | 190 | 2 | 38273746 | |
| Pubmed | HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy. | 2.97e-05 | 2 | 190 | 2 | 34943954 | |
| Cytoband | 5q31 | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 | 5.94e-11 | 115 | 190 | 10 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 HSPA4 HSPA9 | 5.20e-09 | 298 | 190 | 12 | chr5q31 |
| Cytoband | 11q22-q23 | 2.53e-04 | 6 | 190 | 2 | 11q22-q23 | |
| Cytoband | 4q28 | 6.02e-04 | 9 | 190 | 2 | 4q28 | |
| GeneFamily | Clustered protocadherins | PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 PCDHB5 PCDHB12 PCDHA5 PCDHA2 PCDHB1 | 6.38e-11 | 64 | 141 | 10 | 20 |
| GeneFamily | Heat shock 70kDa proteins | 1.54e-07 | 17 | 141 | 5 | 583 | |
| GeneFamily | Fibronectin type III domain containing | FNDC3B COL7A1 PRTG IGSF22 PTPRJ ROBO2 COL14A1 ROBO3 SDK1 IL7R | 5.08e-07 | 160 | 141 | 10 | 555 |
| GeneFamily | Sideroflexins | 4.59e-06 | 5 | 141 | 3 | 746 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.83e-06 | 161 | 141 | 9 | 593 | |
| GeneFamily | Kelch like|BTB domain containing | 3.15e-04 | 42 | 141 | 4 | 617 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 3.18e-04 | 76 | 141 | 5 | 743 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.76e-03 | 66 | 141 | 4 | 722 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.10e-03 | 9 | 141 | 2 | 1234 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 4.01e-03 | 134 | 141 | 5 | 861 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | EPPK1 SPEG PCDHB5 PCDHA5 PCDHA2 TDRD1 OLFM3 DROSHA NLGN2 PCDHB1 | 1.01e-05 | 238 | 190 | 10 | M2020 |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP | 1.64e-05 | 200 | 190 | 9 | M385 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP | 1.64e-05 | 200 | 190 | 9 | M8489 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | EPPK1 SPEG PCDHB5 PCDHA5 PCDHA2 TDRD1 OLFM3 DROSHA NLGN2 PCDHB1 | 2.23e-05 | 261 | 190 | 10 | MM1277 |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | TMEM198 POLR2A ARHGEF10L ITPR2 PTPRJ LIPG TAS1R1 PAK3 CSMD1 ATP2A3 HSPA2 | 6.79e-10 | 191 | 190 | 11 | 54f07e4de61735051498846afb44b1798bed8144 |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | TMEM198 ARHGEF10L ITPR2 LIPG TAS1R1 NAV2 PAK3 CLDN19 CSMD1 ATP2A3 | 3.18e-09 | 169 | 190 | 10 | 05e12524d68d409fed386ffad233305683b4575b |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | NRTN IFT172 TMEM198 ITPR2 PTPRJ LIPG TAS1R1 PAK3 CSMD1 ATP2A3 | 7.58e-09 | 185 | 190 | 10 | 686ed7550c6acd18e71e0076936ec5b07389adbd |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Tuft|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.70e-08 | 178 | 190 | 9 | f17c3b7bb562ac24c6a03fe3c9ba94c2b434c141 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-07 | 148 | 190 | 8 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-07 | 148 | 190 | 8 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-07 | 148 | 190 | 8 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.52e-07 | 168 | 190 | 8 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-06 | 125 | 190 | 7 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 191 | 190 | 8 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 191 | 190 | 8 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-06 | 193 | 190 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-06 | 194 | 190 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.92e-06 | 194 | 190 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 197 | 190 | 8 | 4ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-06 | 198 | 190 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 199 | 190 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-06 | 200 | 190 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-06 | 200 | 190 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.89e-06 | 144 | 190 | 7 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.38e-06 | 166 | 190 | 7 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-06 | 167 | 190 | 7 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-06 | 171 | 190 | 7 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-05 | 177 | 190 | 7 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 178 | 190 | 7 | 3e8aacb27ed1a3c3978e21dddddd0828f8000692 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 179 | 190 | 7 | 906555ce2ca264a0215b120c7ff7c9b411de6a34 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 179 | 190 | 7 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 179 | 190 | 7 | e7045e27f0eb88f552b31c04b56d78e5ccd7a36c | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 180 | 190 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-05 | 180 | 190 | 7 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 181 | 190 | 7 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 181 | 190 | 7 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | facs|World / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 182 | 190 | 7 | 08f775135b451be709f5fc8e1cbcf63425794a2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-05 | 182 | 190 | 7 | ba066ff9029cc052b76e2330ec168cb2e9b7e498 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 182 | 190 | 7 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 182 | 190 | 7 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 183 | 190 | 7 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 183 | 190 | 7 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 184 | 190 | 7 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-Uncommitted_AE_Progenitor|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.48e-05 | 123 | 190 | 6 | 5f002f5180fe47fe57ab888b5f0319df99ab2c59 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-05 | 185 | 190 | 7 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 188 | 190 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 189 | 190 | 7 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 190 | 190 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.77e-05 | 190 | 190 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 191 | 190 | 7 | 5a5b5402a077b3189ca156f2bac5f47ad780aebf | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 191 | 190 | 7 | 78bcce497920cc5b3bef083eab50deb1cc82cd2e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 191 | 190 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 191 | 190 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.83e-05 | 191 | 190 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 191 | 190 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 192 | 190 | 7 | e19e3e8edcc08e4a67873bfb6e46489ca6c8756a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 192 | 190 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 192 | 190 | 7 | 8769b67d1cad1be65da3938f916e5bf88f88f6b8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.90e-05 | 192 | 190 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 192 | 190 | 7 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 192 | 190 | 7 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 192 | 190 | 7 | 61c2caf6c838132ed5faa8791c288f2149eba2c8 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.94e-05 | 129 | 190 | 6 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-05 | 193 | 190 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.96e-05 | 193 | 190 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.03e-05 | 194 | 190 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 194 | 190 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 194 | 190 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.10e-05 | 195 | 190 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.10e-05 | 195 | 190 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.17e-05 | 196 | 190 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 196 | 190 | 7 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.17e-05 | 196 | 190 | 7 | a44a648bf209ce037bfc7b3adfcb220aab60728c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.17e-05 | 196 | 190 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-05 | 197 | 190 | 7 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-05 | 197 | 190 | 7 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.24e-05 | 197 | 190 | 7 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-05 | 197 | 190 | 7 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 198 | 190 | 7 | 688b0eb5534dde40b8630ab8a3252c816711e02e | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.31e-05 | 198 | 190 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 198 | 190 | 7 | 4448d13511485a44fe7b549e4b8b6ad7637db624 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.31e-05 | 198 | 190 | 7 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.31e-05 | 198 | 190 | 7 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 200 | 190 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 200 | 190 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Proliferative_Immature_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.51e-05 | 135 | 190 | 6 | ed0f94d3839eea3b60217c4352159ed481361f13 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-05 | 154 | 190 | 6 | 3211f003f4d1735c7cab9b6cc68af3e0bbfba35e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-05 | 154 | 190 | 6 | 4c2a7590791c2255b15dab82c3622f71f9ffd949 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-05 | 154 | 190 | 6 | c0fe767fc9ab45b2dfa71171f2a673a4a8decbaf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-05 | 157 | 190 | 6 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 160 | 190 | 6 | 174a4ab27114efcc63be36929b80680be3c35c9b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 160 | 190 | 6 | 1e210e526ea4d84fc58a798a26c0929bcb69fd89 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.94e-05 | 162 | 190 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney-Kidney_normal_tissue|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.94e-05 | 162 | 190 | 6 | a0367e9af78e4699b9d89d3e0597589e644f844c | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.94e-05 | 162 | 190 | 6 | 65549ffdbfe8619693345db78e6ddbdde7b742c9 | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.94e-05 | 162 | 190 | 6 | d007ec42d6458431f6c490df61de7a9caef857f0 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 6.94e-05 | 162 | 190 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.94e-05 | 166 | 190 | 6 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 7.94e-05 | 166 | 190 | 6 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-05 | 169 | 190 | 6 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.77e-05 | 169 | 190 | 6 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-05 | 170 | 190 | 6 | f3d5678669dcaed1836014cea543758b7ccc6b46 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.06e-05 | 170 | 190 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.97e-05 | 173 | 190 | 6 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| Disease | mental development measurement | 4.29e-07 | 25 | 184 | 5 | EFO_0008230 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 8.20e-06 | 7 | 184 | 3 | DOID:0060475 (implicated_via_orthology) | |
| Disease | IFAP syndrome | 3.87e-05 | 2 | 184 | 2 | cv:C1839988 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 8.33e-05 | 71 | 184 | 5 | EFO_0007878, EFO_0007979 | |
| Disease | lymphocyte count | ZFAT EPPK1 CEL PCDHGB5 PCDHGB1 PCDHGA10 PCDHGA7 PCDHGA4 KIF1B SREBF1 GPRIN3 RRM1 TDRD1 NIBAN3 ITPR2 MFSD2A PTPRJ NRXN2 ROBO2 ATM VARS1 IL7R | 1.25e-04 | 1464 | 184 | 22 | EFO_0004587 |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 2.15e-04 | 19 | 184 | 3 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 2.15e-04 | 19 | 184 | 3 | C2936783 | |
| Disease | venous thromboembolism, response to surgery | 2.30e-04 | 4 | 184 | 2 | EFO_0004286, EFO_0009951 | |
| Disease | Abnormality of refraction | FNDC3B FAT3 PHRF1 PCDHA5 PCDHA2 TKTL1 ITPR2 MFSD2A FER1L4 BARHL2 FBXO7 PZP SNTB1 | 3.30e-04 | 673 | 184 | 13 | HP_0000539 |
| Disease | Sarcosine measurement | 3.85e-04 | 23 | 184 | 3 | EFO_0021668 | |
| Disease | Immunologic Deficiency Syndromes | 3.85e-04 | 23 | 184 | 3 | C0021051 | |
| Disease | airway responsiveness measurement | 4.38e-04 | 24 | 184 | 3 | EFO_0006897 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 4.38e-04 | 24 | 184 | 3 | DOID:3907 (is_implicated_in) | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 5.58e-04 | 26 | 184 | 3 | C0009405 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 6.25e-04 | 27 | 184 | 3 | C1112155 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 7.74e-04 | 29 | 184 | 3 | C1333990 | |
| Disease | 1,5 anhydroglucitol measurement | 7.74e-04 | 29 | 184 | 3 | EFO_0008009 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 8.56e-04 | 30 | 184 | 3 | DOID:14330 (biomarker_via_orthology) | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 1.04e-03 | 32 | 184 | 3 | DOID:332 (is_implicated_in) | |
| Disease | eating disorder | 1.04e-03 | 32 | 184 | 3 | EFO_0005203 | |
| Disease | Congenital disorder of glycosylation type 1q | 1.06e-03 | 8 | 184 | 2 | C4317224 | |
| Disease | female breast cancer (is_implicated_in) | 1.06e-03 | 8 | 184 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | amino acid measurement | DNAH7 SLC7A2 PTPRJ VCAN GAN COL14A1 STK39 C5 SETD7 CSMD1 UNC5D SNTB1 | 1.19e-03 | 678 | 184 | 12 | EFO_0005134 |
| Disease | nasal disorder | 1.35e-03 | 35 | 184 | 3 | MONDO_0002436 | |
| Disease | coronary aneurysm | 1.35e-03 | 35 | 184 | 3 | EFO_1000881 | |
| Disease | Schizophrenia | SREBF1 LEP NDUFV1 NRXN2 SLC26A7 TSPAN8 DLG4 NLGN2 OXSR1 ATM CSMD1 PCDH8 HSPA9 SLC17A6 | 1.35e-03 | 883 | 184 | 14 | C0036341 |
| Disease | Chronic schizophrenia | 1.35e-03 | 9 | 184 | 2 | C0221765 | |
| Disease | adult respiratory distress syndrome (implicated_via_orthology) | 1.35e-03 | 9 | 184 | 2 | DOID:11394 (implicated_via_orthology) | |
| Disease | Liver carcinoma | 1.38e-03 | 507 | 184 | 10 | C2239176 | |
| Disease | smoking behavior | 1.41e-03 | 341 | 184 | 8 | EFO_0004318 | |
| Disease | sleep latency | 1.59e-03 | 37 | 184 | 3 | EFO_0005280 | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.68e-03 | 10 | 184 | 2 | GO_0097327, GO_0097328 | |
| Disease | Congenital Disorders of Glycosylation | 1.68e-03 | 10 | 184 | 2 | C0282577 | |
| Disease | cortical thickness | PRTG CTTNBP2 ADAMTS2 CPSF6 FAT3 TM7SF3 SREBF1 TENM2 MALRD1 VCAN PKD1 NAV2 ROBO2 KIF5B ZSWIM4 SNTB1 | 1.71e-03 | 1113 | 184 | 16 | EFO_0004840 |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 2.42e-03 | 216 | 184 | 6 | EFO_0007925, EFO_0007927 | |
| Disease | serine protease 27 measurement | 2.45e-03 | 12 | 184 | 2 | EFO_0008280 | |
| Disease | intracranial aneurysm (is_implicated_in) | 2.45e-03 | 12 | 184 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | resting heart rate | 2.48e-03 | 149 | 184 | 5 | EFO_0004351 | |
| Disease | smoking behaviour measurement | 2.77e-03 | 222 | 184 | 6 | EFO_0005671 | |
| Disease | periodontitis | 2.84e-03 | 223 | 184 | 6 | EFO_0000649 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 3.10e-03 | 227 | 184 | 6 | EFO_0004346, EFO_0010736 | |
| Disease | Malignant neoplasm of breast | FNDC3B COL7A1 CTU2 POLH B3GALNT2 LEP EMSY ADHFE1 FGD5 ATM ATP2A3 PCDH8 CNGA2 HSD17B8 SLC17A6 | 3.11e-03 | 1074 | 184 | 15 | C0006142 |
| Disease | disease progression measurement, Crohn's disease | 3.16e-03 | 47 | 184 | 3 | EFO_0000384, EFO_0008336 | |
| Disease | glycodeoxycholate measurement | 3.35e-03 | 14 | 184 | 2 | EFO_0010493 | |
| Disease | Alzheimer disease, visuospatial impairment | 3.35e-03 | 14 | 184 | 2 | EFO_0009752, MONDO_0004975 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 3.35e-03 | 14 | 184 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | HbA1c measurement | FNDC3B CTU2 ZFAT DUSP9 PFKL LEP PTPRJ TAS1R1 STK39 OXSR1 UNC5D | 3.56e-03 | 675 | 184 | 11 | EFO_0004541 |
| Disease | fetal genotype effect measurement, body weights and measures | 3.56e-03 | 49 | 184 | 3 | EFO_0004324, EFO_0007959 | |
| Disease | chronotype measurement | ZFAT NRTN HSDL2 UNC5B TENM2 DNAH1 BARHL2 RHBDL3 PCDH15 PDZD8 ROBO2 CSMD1 UNC5D | 3.72e-03 | 882 | 184 | 13 | EFO_0008328 |
| Disease | unipolar depression | CTTNBP2 HSPA4L CPSF6 PCDHA5 PCDHA2 DNAH7 TENM2 ITPR2 OLFM3 MICAL2 VCAN PKD1 ROBO2 CSMD1 PZP SDK1 | 3.77e-03 | 1206 | 184 | 16 | EFO_0003761 |
| Disease | opioid dependence | 3.82e-03 | 237 | 184 | 6 | EFO_0005611 | |
| Disease | BMI-adjusted leptin measurement | 3.85e-03 | 15 | 184 | 2 | EFO_0007793 | |
| Disease | waist-hip ratio | PLIN4 FNDC3B ZFAT ADAMTS2 DCST2 TLCD2 SH2B1 SLC7A2 BTD BARHL2 SEMA3B PKD1 PDZD8 COL14A1 HSPA4 SNTB1 | 4.40e-03 | 1226 | 184 | 16 | EFO_0004343 |
| Disease | refractive error | 4.51e-03 | 326 | 184 | 7 | MONDO_0004892 | |
| Disease | mean reticulocyte volume | PLIN4 ZFAT CHD1 MAU2 RRM1 TYMP SH2B1 PTPRJ FBXO7 OXSR1 ATM HSPA4 | 4.53e-03 | 799 | 184 | 12 | EFO_0010701 |
| Disease | Streptozotocin Diabetes | 4.74e-03 | 108 | 184 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 4.74e-03 | 108 | 184 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 4.74e-03 | 108 | 184 | 4 | C0002152 | |
| Disease | Benign neoplasm of stomach | 4.95e-03 | 17 | 184 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.95e-03 | 17 | 184 | 2 | C0496905 | |
| Disease | Antibody Deficiency Syndrome | 4.95e-03 | 17 | 184 | 2 | C0003257 | |
| Disease | Carcinoma in situ of stomach | 4.95e-03 | 17 | 184 | 2 | C0154060 | |
| Disease | rhinitis | 4.95e-03 | 17 | 184 | 2 | EFO_0008521 | |
| Disease | food allergy measurement | 4.95e-03 | 17 | 184 | 2 | EFO_0007016 | |
| Disease | Myocardial Ischemia | 5.03e-03 | 176 | 184 | 5 | C0151744 | |
| Disease | depressive symptom measurement | 5.47e-03 | 426 | 184 | 8 | EFO_0007006 | |
| Disease | caudal middle frontal gyrus volume measurement | 5.54e-03 | 18 | 184 | 2 | EFO_0010290 | |
| Disease | Autistic Disorder | 6.07e-03 | 261 | 184 | 6 | C0004352 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 6.17e-03 | 19 | 184 | 2 | EFO_0002609, GO_0031427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YTAVLARSEDDGIGI | 26 | O75528 | |
| ASVLAYASEESVLVG | 561 | Q9BXT4 | |
| LGSIVQSEGSYVESL | 321 | Q9HCE6 | |
| AIGYSFAIVGINITD | 231 | Q8N336 | |
| ANAVLTGELFTYGAV | 2866 | Q96PZ7 | |
| ASAYVSEEEAVTLIG | 1591 | P13611 | |
| TLTQAGYVGEDIESV | 321 | O76031 | |
| SAVGVRVAATYEAGA | 401 | Q96Q42 | |
| GSVTVLSGYAADEIT | 251 | Q6P6C2 | |
| RVGATAAVYSAAILE | 46 | Q71UI9 | |
| AGDAIITAVGLYEGL | 36 | Q8N6F1 | |
| AVASAAKLGAVYTEG | 16 | P19835 | |
| STLGAGVYVLAGEVA | 46 | P52569 | |
| GVYVLAGEVAKADSG | 51 | P52569 | |
| GATGATTTIYAVEAD | 286 | O14646 | |
| ASIVAAVEEGRAIYS | 741 | Q93084 | |
| LYVGDVAGLAEASSV | 156 | O95450 | |
| LYGAAVTTVEGIGST | 81 | Q06278 | |
| LTSVLEAVAGEYALV | 761 | P98198 | |
| AIKGGVEDEATLSAY | 1096 | P20742 | |
| AIDLDEGVNGEVTYS | 266 | Q9Y5G6 | |
| VVVVSARDLDAGAYG | 261 | Q9Y5E4 | |
| IGDIVSLYAEGSVNG | 11 | Q14571 | |
| VGSQALTTEGIYEDV | 561 | Q86XR2 | |
| AIETYDIDIQATDGG | 311 | Q9Y5F3 | |
| AEAGYLVTKVVAVDG | 581 | Q9Y5F3 | |
| AAGSEATLVDVNVYL | 686 | Q9Y5H9 | |
| DYELQEVIGSGATAV | 16 | O95747 | |
| EVIGSGATAVVQAAY | 21 | O95747 | |
| LGNVISALAEGSTYV | 261 | P33176 | |
| RVSELGLGYASDETV | 111 | Q99748 | |
| SSEETVGAVVYAEVG | 791 | Q14207 | |
| DDSGLTLYLVVAVAA | 716 | Q9Y5G9 | |
| QGASGTVYTALDIAT | 291 | O75914 | |
| SSYTVEIFAQVGDGI | 691 | Q12913 | |
| SAVADGRVLVTGGYI | 461 | Q9H511 | |
| LVAVAAAAEYSGTVA | 6 | Q96II8 | |
| QASGIELYAVGVDRA | 211 | O15232 | |
| YTTAEEAAGIGILTV | 21 | Q16655 | |
| YAGVLAVGVGDTVAS | 441 | Q9UPQ8 | |
| AVARAGGIETIANEY | 16 | P34932 | |
| AEYTADVDGVGTLRL | 121 | O60547 | |
| IVLTAVGGEAIYSDE | 36 | Q5T442 | |
| DTSVAYVRGEENLAG | 1466 | O60333 | |
| VAGQGVESEVLASYR | 966 | A9Z1Z3 | |
| ISDADFVLYVGALAT | 206 | Q96KR4 | |
| NGIYTAEILAIDDGS | 461 | Q86SJ6 | |
| EETVSGLKGYVAAGT | 1111 | Q10570 | |
| AYIIEQAGGLATTGT | 286 | O00757 | |
| AVAYGAAVQAAILIG | 371 | P54652 | |
| IEIQAEDGGAYLATA | 321 | Q9Y5H3 | |
| GYLVTKVVAVDADSG | 581 | Q9Y5G3 | |
| VGRAGGAVSTYVSVD | 541 | O95206 | |
| STDGYAGHVIIETVA | 386 | Q8NEN9 | |
| TVTGIAVGADAAYVF | 581 | P17858 | |
| AYTAVEGDEVSLLEG | 236 | P14598 | |
| EVAASGEGSAISGYL | 1356 | Q6ZNL6 | |
| ERGVAYINADSSIEG | 136 | Q9HBA9 | |
| AVLVRVDSASGLGDY | 1176 | Q9P2S2 | |
| LASYVTGAVLVADGG | 256 | Q9NUI1 | |
| ELYESARIGGALSVA | 31 | Q99956 | |
| EAIEAVATGLSTAVY | 311 | Q9P1Y6 | |
| EGTLADTEAGYVAQL | 386 | Q2M2I5 | |
| ETLDSLGGVLEASGY | 126 | P41159 | |
| LGGVLEASGYSTEVV | 131 | P41159 | |
| DVLGSIAYGTITEVV | 256 | Q9Y5X9 | |
| LGTIYTAAEEIEAVG | 51 | Q6YN16 | |
| VFSLLQVVSGESGYA | 11 | P16871 | |
| GSTLEEVYGSVAKVA | 996 | Q07864 | |
| DYGAGTEAAVLLAAE | 271 | A6NEQ2 | |
| GYLVTKVVAVDADSG | 581 | Q9Y5G0 | |
| SVSVYELVVTARDGG | 416 | Q9Y5H7 | |
| YASEAIKGAVVGIDL | 46 | P38646 | |
| EIVAGSDDYTNLVGA | 741 | A8MWY0 | |
| TAEVYAAGKAEVVLG | 86 | Q13303 | |
| AIESYSIIIQATDGG | 311 | Q9Y5F1 | |
| STYLAVAEELADVSG | 271 | Q8NBN7 | |
| TTVAYTLDEGLIEFG | 586 | Q9UG01 | |
| ERGAYEASLVAASTG | 1666 | Q9UG01 | |
| EVLSNGSLYISEVEG | 86 | Q2VWP7 | |
| ITYAVAVAAGISVAA | 396 | Q8NA29 | |
| RGISYIGDVAVDDIS | 1236 | Q5VYJ5 | |
| ADEGSNGEITYEILV | 536 | Q96QU1 | |
| NISGDVLVAAGFVAY | 3146 | Q9P2D7 | |
| VATSSIVGYILGLGD | 2856 | Q13315 | |
| IIEDAQLSDGGEYTV | 476 | Q8N9C0 | |
| SSAGVAVLEGALYVA | 521 | Q6TDP4 | |
| SSSVLDGLLYVVAAD | 376 | Q9UJP4 | |
| ASAGDYGSAIETLVT | 436 | Q16630 | |
| VAYVAAQLVGATVGA | 101 | Q13520 | |
| IDRQASYGDLIGASV | 356 | Q8WZ74 | |
| LTGDEETLASYGIVS | 56 | Q9Y3I1 | |
| GTEYEVSLLAVLDDG | 686 | Q05707 | |
| AIGVADADYSELVSI | 1166 | Q05707 | |
| LAYTIDLGDTSITVG | 901 | Q53EP0 | |
| VVAFLASEDSGYITG | 236 | Q92506 | |
| GASIYVIGDLDTGTN | 526 | Q9H2C0 | |
| VITSLGVFYDANDVG | 156 | Q8NCR0 | |
| ALAAVDSAVYGVQRG | 601 | P01031 | |
| GDILISSGVVAYLGA | 2906 | Q8WXX0 | |
| VVYSLADSAGGVFSI | 3166 | Q8TDW7 | |
| YSAVISEDALVGDSV | 3346 | Q8TDW7 | |
| YVVALGAHTGEESVA | 36 | P43251 | |
| ILDGVAVSTAARAYG | 16 | A8MV24 | |
| TAVGLELLAEAGNYS | 291 | Q9NY43 | |
| DNSIYVTKIIEGGAA | 186 | P78352 | |
| GISVGSYLDTLADDV | 176 | Q8IV03 | |
| AITGTAKEAVVVDYG | 571 | P49641 | |
| YVLPIGDADAAAAVT | 116 | Q9H9H5 | |
| YTGVGVLITEVAEDS | 251 | O43462 | |
| GYGDTDARVTAAIAS | 36 | Q9Y2Q5 | |
| RVGATAAVYSAAILE | 46 | P0C0S5 | |
| GGVSYSVRVTALVGD | 836 | Q02388 | |
| EAYAGVISALRAQGD | 26 | Q7Z589 | |
| LVSLTVEGTGYAGNI | 451 | Q5T1A1 | |
| YGASLDAESLGIAIQ | 696 | Q6ZVF9 | |
| DGSALAAYGDVVVVT | 161 | Q6UWW8 | |
| DEAVAYGAAVQAGVL | 391 | P11021 | |
| YTIDVAAVTAVGTGL | 1041 | Q7Z5N4 | |
| IYNGGVEAVSTLLGA | 331 | O60779 | |
| DLLGVGAEYARVVGS | 166 | Q9Y6X3 | |
| AEGLGVAVYAAAVLL | 361 | Q6NUT3 | |
| FDGSVLAAYGNVIVA | 196 | Q8NFZ4 | |
| ELVGSEGAYKAAVDS | 166 | Q2VPK5 | |
| SAVLTGIQEEIGAYD | 181 | Q96PB7 | |
| VVEESELARTAGYGI | 146 | P02748 | |
| SSGIGAAAEVLVNLY | 956 | O94851 | |
| VTLSAELAGGSGVVY | 1736 | P98161 | |
| TGGVDTAAVADVYDI | 356 | P17540 | |
| VDDGLAAVGYSKADI | 416 | Q8IWW8 | |
| CELYGIVASAGSVEE | 1296 | Q96Q06 | |
| EATGALASAVSGYVQ | 1141 | P26640 | |
| SGYVQALASAGVVAV | 1151 | P26640 | |
| VGAGLYVAVVVALAA | 216 | A6NDD5 | |
| SGIIVTLAGVYLSDG | 216 | P78382 | |
| ALIGAVYLEGSLEEA | 1046 | Q9NRR4 | |
| LESGGSSDVVLVSYV | 611 | Q9NRF2 | |
| LVLSSEEGAAAYNGI | 46 | Q13884 | |
| VADEAGQRLGYSVTA | 206 | Q9BWM7 | |
| ELGTAYVSATTGAVA | 146 | Q9H9B4 | |
| GGETYGVSLESLQLA | 356 | Q9HC36 | |
| GLVYVAGVVAGSLAV | 251 | P58872 | |
| GGETLYVTADLTLED | 1126 | A1L390 | |
| AGAYICGEETALIES | 201 | P49821 | |
| VLASGYVSGAAREEL | 4676 | P58107 | |
| GLNSDSVLGYSIGEI | 2076 | Q8IVL1 | |
| AGLYVALAVGVSEES | 571 | Q6P5W5 | |
| SGVEYTRLAVETAQG | 411 | Q9H3S1 | |
| EGLVDTAVKTAETGY | 856 | O14802 | |
| VYVAESLISSAGEGL | 216 | Q8WTS6 | |
| AITAVYTVAGGLAAV | 186 | Q8WWX8 | |
| VALAVGIDGSLYVGD | 1241 | Q9NT68 | |
| GIIAVSYEARAFGVT | 46 | Q9Y253 | |
| AATSGVGIDGEVLSY | 586 | O94844 | |
| SGSSVLQGVEADLYL | 301 | Q9GZT8 | |
| SASVAGAREGDYIVS | 546 | Q8IUC4 | |
| LQLYTEDGTAVASVG | 536 | Q5JTZ9 | |
| AGDAVSVATLAEIYV | 706 | P36956 | |
| TGLVGGTLVAVYAVA | 41 | Q6P4H8 | |
| AVTIAAGTAAIGYLA | 16 | Q9NZ45 | |
| VVADDGVTQYALLSA | 501 | Q16280 | |
| GIYEEGISILESSSA | 76 | Q12933 | |
| YIEESIGESANLLGA | 281 | Q9P2U8 | |
| EYANVGTGELAAEVL | 1021 | Q9P243 | |
| ISLVGSSDDYGQLGV | 211 | Q7RTX1 | |
| AAVGTANGTVYLLDL | 1691 | Q99973 | |
| LVAVSVGYFLADGAD | 81 | A6NGC4 | |
| VGSEDEGLYAVSAVN | 1126 | Q15772 | |
| SLVVLSTGAQDGGVY | 1541 | Q15772 | |
| GLYSGVTTVELDTLA | 46 | P23921 | |
| AGGLAAVIYTDALQT | 186 | A0PJK1 | |
| AVARSGGIETIANEY | 16 | O95757 | |
| AASVLVGEELYSGVA | 176 | Q13214 | |
| YRTLVAAATSAGVGV | 841 | Q96MS0 | |
| GLIDTAVKTAETGYI | 846 | P24928 | |
| LGYVSGALISDLETD | 1201 | Q9HCK4 | |
| SGDAALYAGLVVAIF | 371 | Q8IZJ1 | |
| ALYSGLGAAVVAVAV | 381 | Q6UXZ4 | |
| EAGDVIYIEANSGAV | 186 | Q9Y265 | |
| EVRDGVAVLDAGSYV | 506 | Q96NZ8 | |
| VAVLDAGSYVRAASE | 511 | Q96NZ8 | |
| DGAIALTGVDEAYTL | 171 | Q9NQH7 | |
| DSLQAYAAGVVEAAV | 111 | Q8NHP8 | |
| YAAGVVEAAVSEELI | 116 | Q8NHP8 | |
| LDDAGVYTAEVIRAG | 271 | Q86VR7 | |
| VFAVGDLDSIYGTEA | 91 | Q6UWW9 | |
| VIVAADSRATAGAYI | 71 | P28074 | |
| SAVITEAFGVALVGY | 306 | Q8TE54 | |
| EAFGVALVGYVASLA | 311 | Q8TE54 | |
| GYLGAVISAVSIAVG | 166 | Q8TD22 | |
| DAYELQEVIGSGATA | 61 | Q9UEW8 | |
| FADGLGVAEAISYVD | 556 | O43164 | |
| ASDTELYDLAAVLGV | 126 | Q9NZR1 | |
| GILYAARDVTATVDS | 196 | P19971 | |
| GAGITVYEALAAADE | 481 | P51854 | |
| EDVGSSSYVAVDILI | 46 | P19075 | |
| TAVTGAALIATAADY | 176 | Q66K66 | |
| YHAGEVLSGVVVISS | 16 | O14972 | |
| GVIGSYSVVLAIDSY | 436 | Q9NS93 | |
| YDIRTNAVTVGGVAA | 206 | O60635 | |
| TEGYSGADISIIVRD | 326 | Q9UN37 | |
| EAAYQIVLDAAAGGL | 786 | Q9H7M6 | |
| QEVEVDGLTAYVAGT | 311 | Q9Y303 |